60893-02-9 Usage
General Description
Gamma-endorphin is a neuropeptide and endorphin that is part of the endorphin family, known for its pain-relieving and mood-enhancing effects. It is a naturally occurring opioid that is produced in the pituitary gland and central nervous system, and acts as a neurotransmitter in the brain. Gamma-endorphin is released in response to stress or pain and is believed to be involved in the body's natural pain management system. It has been found to play a role in regulating mood, reducing anxiety, and promoting a sense of well-being. Additionally, gamma-endorphin has been linked to the regulation of the immune system and may have potential therapeutic applications in the treatment of chronic pain and mood disorders. Overall, gamma-endorphin is a key player in the body's response to stress, pain, and emotional well-being.
Check Digit Verification of cas no
The CAS Registry Mumber 60893-02-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,8,9 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60893-02:
(7*6)+(6*0)+(5*8)+(4*9)+(3*3)+(2*0)+(1*2)=129
129 % 10 = 9
So 60893-02-9 is a valid CAS Registry Number.
60893-02-9Relevant articles and documents
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication
Merlino, Francesco,Tomassi, Stefano,Yousif, Ali M.,Messere, Anna,Marinelli, Luciana,Grieco, Paolo,Novellino, Ettore,Cosconati, Sandro,Di Maro, Salvatore
supporting information, p. 6378 - 6382 (2019/09/06)
We investigated the ultrasonication-mediated effects on the Fmoc-based solid-phase peptide synthesis (SPPS). Our study culminated with the development of an ultrasound-assisted strategy (US-SPPS) that allowed for the synthesis of different biologically active peptides (up to 44-mer), with a remarkable savings of material and reaction time. Noteworthy, ultrasonic irradiation did not exacerbate the main side reactions and improved the synthesis of peptides endowed with "difficult sequences", placing the US-SPPS among the current high-efficient peptide synthetic strategies.
